Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer

Clinical Laboratory

Volumn 55, Issue 5-6, 2009, Pages 187-192

  Montagnana, Martina ^a,b   Minicozzi, Anna Maria ^a   Salvagno, Gian Luca ^a   Danese, Elisa ^a   Cordiano, Claudio ^a   De Manzoni, Giovanni ^a   Guidi, Gian Cesare ^a   Lippi, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

C reactive protein; Gastrointestinal cancer; Inflammation; Procalcitonin, surgery

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SURGERY; HISTOPATHOLOGY; HUMAN; MALE; POSTOPERATIVE PERIOD; ROC CURVE; STOMACH CARCINOMA; SURGICAL INFECTION;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COLORECTAL NEOPLASMS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MONITORING, PHYSIOLOGIC; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROTEIN PRECURSORS; REFERENCE VALUES; STOMACH NEOPLASMS; TIME FACTORS; WOUND HEALING;

BACTERIA (MICROORGANISMS);

EID: 69049118045     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. MacFarlane AJ, Stover PJ. Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev 2007; 65: S157-66.
2. Schottelius AJ, Dinter H. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat Res 2006; 130: 67-87.
3. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007; 97: 1266-1270
4. Holmdahl L, Ivarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur J Surg 1999; 165: 1012-1019
5. diZerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997; 577: 10-16
6. Nagy JA, Jackman R. Response of the peritoneal membrane to injury. Semin Dialysis 1998; 11: 242-248
7. Schüttrumpf S, Binder L, Hagemann T, Berkovic D, Trümper L, Binder C. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003; 82: 98-103.
8. Du Clos TW, Mold C. The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 2001; 14: 289-293
9. Fischer CL, Gill C, Forrester MG, Nakamura R. Quantitation of "acute-phase proteins" postoperatively: value in detection and monitoring of complications. Am J Clin Pathol 1976; 66: 840-846
10. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 9: 1605-1608
11. Maruna P, Nedelnikova K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000; 49: S57-61.
12. Kallio R, Surcel HM, Bloigu A, Syrjala H. Creactive protein, procalcitonin and interleukin 8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000; 36: 889-894
13. Karzai W, Oberhoffer M, MeierHellmann A, Reinhart K. Procalcitonin - a new indicator of the systemic response to severe infection. Infection 1997; 25: 329-334
14. Ilhan N, Ilhan N, Ilhan Y, Akbulut H, Küçüksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 2004; 10: 1115-1120
15. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20: 633-649
16. Boyle P, Leon ME. Epidemiology of colorectal cancer. Br Med Bull 2002; 64: 1-25.
17. Horzic M, Kopljar M. Postoperative infections in colorectal cancer patients. Hepatogastroenterology 2005; 52: 101-104
18. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C. Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis 2006; 43: 468-473
19. Jass JR Sobin LH, Watanabe H. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 1990; 66: 2162-2167
20. Wolters U, Wolf T, Stützer H, Schröder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77: 217-222
21. Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 2004; 306: 966-968
22. Robertson G, Liddle C, Clarke S. Inflammation and Altered Drug Clearance in Cancer: Transcriptional Repression of a Human CYP3A4 Transgene in Tumor-bearing Mice. Clin Pharmacol Ther 2008 Mar 26 [Epub ahead of print].
23. Shimetani N, Shimetani K, Mori M. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein. Scand J Clin Lab Invest 2004; 64: 469-474
24. Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA, Hoksch B. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 2008; 33: 777-780
25. Gambino R. C-reactive protein-undervalued, underutilized. Clin Chem 1997; 43: 2017-2018
26. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20: 1-9.
27. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3: 45-50.
28. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation. Cardiovasc Surg 2000; 8: 550-554